Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma.
Padrão NA, Monteiro-Reis S, Torres-Ferreira J, Antunes L, Leça L, Montezuma D, Ramalho-Carvalho J, Dias PC, Monteiro P, Oliveira J, Henrique R, Jerónimo C. Padrão NA, et al. Among authors: torres ferreira j. Br J Cancer. 2017 Feb 28;116(5):634-639. doi: 10.1038/bjc.2016.454. Epub 2017 Jan 12. Br J Cancer. 2017. PMID: 28081549 Free PMC article.
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J, Martins JB, Cekaite L, Sveen A, Torres-Ferreira J, Graça I, Costa-Pinheiro P, Eilertsen IA, Antunes L, Oliveira J, Lothe RA, Henrique R, Jerónimo C. Ramalho-Carvalho J, et al. Among authors: torres ferreira j. Cancer Lett. 2017 Jan 28;385:150-159. doi: 10.1016/j.canlet.2016.10.028. Epub 2016 Oct 27. Cancer Lett. 2017. PMID: 27984115
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
Torres-Ferreira J, Ramalho-Carvalho J, Gomez A, Menezes FD, Freitas R, Oliveira J, Antunes L, Bento MJ, Esteller M, Henrique R, Jerónimo C. Torres-Ferreira J, et al. Mol Cancer. 2017 Jan 31;16(1):26. doi: 10.1186/s12943-017-0604-0. Mol Cancer. 2017. PMID: 28143614 Free PMC article.
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C, Barros-Silva D, Costa-Pinheiro P, Torres-Ferreira J, Constâncio V, Freitas R, Oliveira J, Antunes L, Henrique R, Jerónimo C. Moreira-Barbosa C, et al. Among authors: torres ferreira j. Clin Epigenetics. 2018 Oct 29;10(1):132. doi: 10.1186/s13148-018-0564-2. Clin Epigenetics. 2018. PMID: 30373654 Free PMC article.
MicroRNA-375 plays a dual role in prostate carcinogenesis.
Costa-Pinheiro P, Ramalho-Carvalho J, Vieira FQ, Torres-Ferreira J, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Costa-Pinheiro P, et al. Among authors: torres ferreira j. Clin Epigenetics. 2015 Apr 10;7(1):42. doi: 10.1186/s13148-015-0076-2. eCollection 2015. Clin Epigenetics. 2015. PMID: 25977730 Free PMC article.
Anti-neoplastic properties of hydralazine in prostate cancer.
Graça I, Sousa EJ, Costa-Pinheiro P, Vieira FQ, Torres-Ferreira J, Martins MG, Henrique R, Jerónimo C. Graça I, et al. Among authors: torres ferreira j. Oncotarget. 2014 Aug 15;5(15):5950-64. doi: 10.18632/oncotarget.1909. Oncotarget. 2014. PMID: 24797896 Free PMC article.
DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness.
Carrier A, Desjobert C, Ponger L, Lamant L, Bustos M, Torres-Ferreira J, Henrique R, Jeronimo C, Lanfrancone L, Delmas A, Favre G, Daunay A, Busato F, Hoon DSB, Tost J, Etievant C, Riond J, Arimondo PB. Carrier A, et al. Among authors: torres ferreira j. Elife. 2022 Sep 20;11:e78587. doi: 10.7554/eLife.78587. Elife. 2022. PMID: 36125262 Free PMC article.